27.11.2017 22:10:00

Commercial Metals Company Names Barbara Smith Chairman

IRVING, Texas, Nov. 27, 2017 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) today announced that Barbara Smith, the Company's President and Chief Executive Officer, will also become the Chairman of the Board, effective January 11, 2018.  Ms. Smith has been a director since her promotion to Chief Executive Officer on September 1, 2017.  Mr. Joseph Alvarado, CMC's current Chairman, will be retiring from the Board and Mr. Richard Kelson will continue as the Company's Lead Director.

"The Board's decision to appoint Barbara as Chairman is a reflection of her leadership and substantial contributions to the Company's operating and financial performance since joining the company in 2011," stated Mr. Kelson.  "The appointment will also promote unified leadership for the Company, allowing for a single clear focus for management to execute its strategy and business plans."

About Commercial Metals Company

Commercial Metals Company and its subsidiaries manufacture, recycle and market steel and metal products, related materials and services through a network including four electric arc furnace ("EAF") mini mills, an EAF Micro mill, a rerolling mill, steel fabrication and processing plants, construction-related product warehouses, metal recycling facilities and marketing and distribution offices in the United States and in strategic international markets.

 

View original content:http://www.prnewswire.com/news-releases/commercial-metals-company-names-barbara-smith-chairman-300561995.html

SOURCE Commercial Metals Company

Analysen zu Lennox International Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Commercial Metals Co. 54,58 -2,99% Commercial Metals Co.
Lennox International Inc. 629,60 0,32% Lennox International Inc.
Lexicon Pharmaceuticals Inc 0,81 -1,45% Lexicon Pharmaceuticals Inc